PMC:7796052 / 439-655 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"15","span":{"begin":99,"end":109},"obj":"Gene"},{"id":"18","span":{"begin":1,"end":9},"obj":"Species"},{"id":"19","span":{"begin":123,"end":133},"obj":"Chemical"},{"id":"22","span":{"begin":22,"end":30},"obj":"Disease"}],"attributes":[{"id":"A15","pred":"tao:has_database_id","subj":"15","obj":"Gene:3827"},{"id":"A18","pred":"tao:has_database_id","subj":"18","obj":"Tax:9606"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"MESH:D020849"},{"id":"A22","pred":"tao:has_database_id","subj":"22","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" patients with severe Covid-19. In the scope of a drug repurposing campaign undertaken to identify bradykinin antagonists, raloxifene was identified as prospective compound in a virtual screening process. The pharmac"}

{"project":"LitCovid-sentences","denotations":[{"id":"T5","span":{"begin":32,"end":204},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" patients with severe Covid-19. In the scope of a drug repurposing campaign undertaken to identify bradykinin antagonists, raloxifene was identified as prospective compound in a virtual screening process. The pharmac"}